Aseptic processing: Reducing contamination risk with SBV technology

摘要

Demand has grown for improved operational efficiency as well as greater quality control and reduced costs relating to manufacturing processes. A key challenge facing an increasing number of drug and ingredient suppliers is the need to eliminate the risk of contamination. The use of effective containment strategies and the close monitoring of critical processes have become critical. Amid the COVID-19 crisis, the global market for aseptic processing was valued at $62. 2 billion during 2020 and is projected to reach a revised size of $73. 6 billion by 2027. Owing to the growing demand for safe, sterile products, technologies that are used in aseptic processing have seen considerable innovations in recent years. However, an ever-greater emphasis is being placed on the further cost reductions, process efficiencies and quality improvements that these solutions can offer.